drugset / Trial / NCT00944424
Phase III Trial of High Dose vs. Standard Dose Vit D2 With Docetaxel in Met Breast ca
RandomizedParallel-groupSingle-blindTreatment
Summary
Randomized phase III trial to determine the effectiveness of High dose versus Standard dose of Vitamin D2 (Ergocalciferol) given with Docetaxel in patients with metastatic breast cancer
Timeline
- Start
- 2009-07
- Primary completion
- 2012-07
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ergocalciferol | Small molecule | — | — |
| Background | Docetaxel | Small molecule | — | — |